Short answer
RET can be tested in tumor tissue or in a germline sample such as blood or saliva. A tumor-only RET result may help guide cancer treatment, but it does not always prove inherited MEN2 risk for relatives. A germline RET pathogenic variant can affect medullary thyroid cancer risk, endocrine surveillance, and cascade testing. The first question is what sample was tested and whether confirmatory germline testing is needed.
Why sample type matters
| Result context | Common next question | Why it matters |
|---|---|---|
| RET found on tumor panel | Was germline testing recommended? | Tumor findings may or may not be inherited. |
| RET found on blood or saliva | Is it pathogenic, likely pathogenic, or uncertain? | Classification drives family follow-up. |
| Medullary thyroid cancer context | Has endocrine genetics reviewed the case? | MEN2 and family testing may matter. |
What tumor-only can prove
Tumor-only testing can show that RET is relevant to the cancer sitting in front of the clinician, but it cannot always tell whether the variant is inherited. That is why tumor-only reports often trigger a second question instead of closing the case.
What germline adds
Germline testing asks a different question: is the RET variant present in the person's inherited DNA? If yes, family counseling, relatives, and MEN2 surveillance may all change.
Questions to ask
- Was the RET result from tumor tissue, blood, saliva, or paired tumor-normal testing?
- Does the report call the finding somatic, germline, possible germline, or variant of uncertain significance?
- Is the exact RET variant associated with MEN2, medullary thyroid cancer, or a treatment biomarker?
- Should relatives wait for germline confirmation before targeted family testing?
When follow-up matters more
Follow-up matters more when a hereditary tumor result could change who in the family should be tested, when tumor-only and germline questions are still mixed together, or when a specialist plan should decide surveillance timing rather than a single lab result. Genetics counseling helps keep the finding tied to the actual family question.
FAQ
What is the difference between tumor-only and germline RET testing?
Tumor-only testing looks at cancer tissue and can guide treatment; germline testing looks for an inherited variant that may matter to relatives.
Why does sample type matter so much?
Because blood, saliva, and tumor tissue answer different questions, and the sample type decides whether family risk is being addressed.
Can a tumor-only RET result prove MEN2 risk?
Not by itself. It may raise the question, but germline confirmation is usually what settles inherited risk.
Does germline testing replace tumor testing?
No. The two tests answer different questions and can both matter in the same case.
Can relatives wait until germline confirmation?
Usually yes, because targeted family testing should follow the correct result type.
What should I ask the oncologist or genetics team?
Ask what sample was tested, whether the result is somatic or germline, and whether family testing should start now or after confirmation.